|
Novozymes sells more than 600 products in more than 40 different industries in 130 countries worldwide. Sales of enzymes and microorganisms account for 95% and 5% respectively of Novozymes’ business.
Biotechnology for industry
Novozymes’ biological solutions form part of many different industrial processes and are therefore involved in the manufacture of a very wide range of products.
Whether we are talking about enzymes, ingredients for the biopharmaceutical industry, or microorganisms, Novozymes’ goal is to use biotechnology as a new and better solution in industry, and as a solution that can promote sustainability in a broad sense. This is one of the ways in which we can work with other companies towards sustainable development. We are convinced that modern biotechnology and its application to industrial problems are a key way forward in this respect.
Sales and markets
Novozymes generated healthy sales growth in 2006. Sales increased by 8% to DKK 6,802 million from DKK 6,281 million in 2005. Growth in local currencies was 9%, and organic growth was just above 7%.
The main growth engines for Novozymes in 2006 were developments in the developing markets and in bioethanol.
Enzymes for industrial use
Enzymes for industrial use account for 95% of Novozymes’ sales, making them our largest business segment. They are divided into the following categories:
| 